GSE146854: Transcriptome analysis of activated CD4+ T cells treated either with sodium butyrate or bufexamac

Gene Expression Data Explorer
Enter gene symbol:
Description

Submission Date: Mar 12, 2020

Summary: Sodium butyrate and bufexamac treatment of activated CD4+ T cells impairs de novo HIV-1 infection. RNAseq was used to obtain information about the cellular changes upon treatment, which could explain the observed effects on HIV-1 infection

GEO Accession ID: GSE146854

PMID: No Pubmed ID

Select conditions below to toggle them from the plot:

GROUP CONDITION SAMPLES
blood cell
GSM4407898 GSM4407899 GSM4407900
GSM4407904 GSM4407905 GSM4407906
GSM4407901 GSM4407902 GSM4407903
Description

Submission Date: Mar 12, 2020

Summary: Sodium butyrate and bufexamac treatment of activated CD4+ T cells impairs de novo HIV-1 infection. RNAseq was used to obtain information about the cellular changes upon treatment, which could explain the observed effects on HIV-1 infection

GEO Accession ID: GSE146854

PMID: No Pubmed ID

Select conditions:

Control Condition

Perturbation Condition

Differential Gene Expression Analysis
Select differential expression analysis method:
Bulk RNA-seq Appyter

This pipeline enables you to analyze and visualize your bulk RNA sequencing datasets with an array of downstream analysis and visualization tools. The pipeline includes: PCA analysis, Clustergrammer interactive heatmap, library size analysis, differential gene expression analysis, enrichment analysis, and L1000 small molecule search.